Signature Estate & Investment Advisors’s iShares Global Healthcare ETF IXJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.82M Buy
18,516
+85
+0.5% +$8K 0.03% 184
2026
Q1
$1.72M Sell
18,431
-808
-4% -$79.1K 0.03% 187
2025
Q4
$1.87M Buy
19,239
+388
+2% +$36.7K 0.04% 169
2025
Q3
$1.67M Sell
18,851
-674
-3% -$58.3K 0.04% 187
2025
Q2
$1.68M Sell
19,525
-398
-2% -$34.2K 0.04% 172
2025
Q1
$1.82M Hold
19,923
0.05% 147
2024
Q4
$1.71M Sell
19,923
-71
-0.4% -$6.56K 0.04% 155
2024
Q3
$1.96M Sell
19,994
-31
-0.2% -$3.01K 0.05% 129
2024
Q2
$1.86M Buy
+20,025
New +$1.83M 0.05% 138

Other funds holding IXJ

Signature Estate & Investment Advisors's IXJ Position: Q2 2026 in Review

Signature Estate & Investment Advisors increased its iShares Global Healthcare ETF (IXJ) stake by 0.46% in Q2 2026, buying an estimated $8K and bringing the position to 18,516 shares worth $1.82M. The position accounts for 0.03% of the portfolio, ranked #184.

Signature Estate & Investment Advisors first reported a position in IXJ in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.96M in Q3 2024. 176 funds tracked by Wall St. Rank hold IXJ as of Q2 2026.

  • Signature Estate & Investment Advisors held 18,516 shares of iShares Global Healthcare ETF worth $1.82M as of Q2 2026.
  • Signature Estate & Investment Advisors bought 85 iShares Global Healthcare ETF shares in Q2 2026, an estimated $8K.
  • iShares Global Healthcare ETF made up 0.03% of Signature Estate & Investment Advisors's portfolio in Q2 2026, its #184 holding.
  • Signature Estate & Investment Advisors first reported a position in iShares Global Healthcare ETF in Q2 2024 and has held it in 9 quarters since.
  • Signature Estate & Investment Advisors's iShares Global Healthcare ETF position peaked at $1.96M in Q3 2024.
  • 176 funds tracked by Wall St. Rank held iShares Global Healthcare ETF as of Q2 2026.

Based on Signature Estate & Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.